GGrantIndex
← Leaderboards

Arnold Bakker

Johns Hopkins University

$10,680,906
Attributed
$17,148,495
Total exposure
8
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.2M · FY201525
$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$17,148,495 · 8

By mechanism

R01$11,635,986 · 4
P30$4,550,988 · 3
P50$961,521 · 1

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposS DiseaseParticipantResolutionRestTau ProteinsDiagnosisFunctional DisorderBrain RegionBrainStructureCognitiveImageTau-1Brain ImagingFunctional Magnetic Resonance ImagingAmyloid Beta-ProteinImaging ModalityNeuroimagingDesignImpaired CognitionFollow-UpMild Cognitive ImpairmentPathology

Grant awards (27)

Anxiety in Parkinson’s disease: using fMRI to evaluate amygdala networks in the on and off dopamine state$742,576
R01 · FY2025 · MH
Visual hallucinations and memory impairment in Parkinson's Disease: The role of hippocampal networks$621,339
R01 · FY2025 · MH · contact PI
Core F: Imaging Biomarker Core$491,746
P30 · FY2025 · AG · contact PI
Core F: Biomarker Core$846,260
P30 · FY2024 · AG · contact PI
Advanced MR Imaging of Olfactory Impairment in Prodromal Alzheimer's Disease$753,886
R01 · FY2024 · AG
Imaging the alpha7 nicotinic acetylcholine receptor in mild cognitive impairment$753,105
R01 · FY2024 · AG
Visual hallucinations and memory impairment in Parkinson's Disease: The role of hippocampal networks$620,781
R01 · FY2024 · MH · contact PI
Core F: Biomarker Core$1,081,575
P30 · FY2023 · AG · contact PI
Advanced MR Imaging of Olfactory Impairment in Prodromal Alzheimer's Disease$768,374
R01 · FY2023 · AG
Imaging the alpha7 nicotinic acetylcholine receptor in mild cognitive impairment$763,712
R01 · FY2023 · AG
Visual hallucinations and memory impairment in Parkinson's Disease: The role of hippocampal networks$592,923
R01 · FY2023 · MH · contact PI
Core F: Biomarker Core$965,132
P30 · FY2022 · AG · contact PI
Advanced MR Imaging of Olfactory Impairment in Prodromal Alzheimer's Disease$782,963
R01 · FY2022 · AG
Imaging the alpha7 nicotinic acetylcholine receptor in mild cognitive impairment$767,806
R01 · FY2022 · AG
Visual hallucinations and memory impairment in Parkinson's Disease: The role of hippocampal networks$614,990
R01 · FY2022 · MH
Advanced MR Imaging of Olfactory Impairment in Prodromal Alzheimer's Disease$797,494
R01 · FY2021 · AG
Imaging the alpha7 nicotinic acetylcholine receptor in mild cognitive impairment$781,729
R01 · FY2021 · AG
Visual hallucinations and memory impairment in Parkinson's Disease: The role of hippocampal networks$669,582
R01 · FY2021 · MH
Core F: Biomarker Core$645,127
P30 · FY2021 · AG · contact PI
Imaging the alpha7 nicotinic acetylcholine receptor in mild cognitive impairment$809,869
R01 · FY2020 · AG
Advanced MR Imaging of Olfactory Impairment in Prodromal Alzheimer's Disease$794,857
R01 · FY2020 · AG
Core F: Biomarker Core$521,148
P30 · FY2020 · AG · contact PI
Hippocampal and parietal network changes among subjects in the early phases of AD and relationship with CSF biomarkers$196,503
P50 · FY2019 · AG · contact PI
Hippocampal and parietal network changes among subjects in the early phases of AD and relationship with CSF biomarkers$193,728
P50 · FY2018 · AG · contact PI
Hippocampal and parietal network changes among subjects in the early phases of AD and relationship with CSF biomarkers$185,131
P50 · FY2017 · AG · contact PI
Hippocampal and parietal network changes among subjects in the early phases of AD and relationship with CSF biomarkers$185,572
P50 · FY2016 · AG · contact PI
Hippocampal and parietal network changes among subjects in the early phases of AD and relationship with CSF biomarkers$200,587
P50 · FY2015 · AG · contact PI